BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Clinical Outcome
38 results:

  • 1. Modifier Role of Common
    Skalniak A; Trofimiuk-Müldner M; Przybylik-Mazurek E; Hubalewska-Dydejczyk A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769224
    [No Abstract]    [Full Text] [Related]  

  • 2. Cystic ovarian teratoma as a novel tumor and growth hormone deficiency as a new condition presenting in Multiple Endocrine Neoplasia type 2B: Case reports and review of the literature.
    Pomahacova R; Paterova P; Nykodymova E; Vaclavikova E; Sykorova P; Personova K; Katra R; Subrt I; Sykora J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Mar; 166(1):105-111. PubMed ID: 34446941
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Correlation of molecular data with histopathological and clinical features in a series of 66 patients with medullary thyroid carcinoma.
    Moura MM; Cabrera RA; Esteves S; Cavaco BM; Soares P; Leite V
    J Endocrinol Invest; 2021 Sep; 44(9):1837-1846. PubMed ID: 33575974
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. RET Copy Number Alteration in Medullary thyroid cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency.
    Ramone T; Mulè C; Ciampi R; Bottici V; Cappagli V; Prete A; Matrone A; Piaggi P; Torregrossa L; Basolo F; Elisei R; Romei C
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33383911
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Modulatory Role of Single Nucleotide Polymorphisms of Distinct Genetic Pathways on clinical Behavior of Medullary thyroid Carcinoma.
    Mishra V; Kowtal P; Rane P; Sarin R
    Asian Pac J Cancer Prev; 2020 May; 21(5):1289-1293. PubMed ID: 32458635
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Radioguided occult lesion localization in patients with recurrent thyroid cancer.
    Tuncel M; Süslü N
    Eur Arch Otorhinolaryngol; 2019 Jun; 276(6):1757-1766. PubMed ID: 30887167
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Current Advances in thyroid cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
    Rusinek D; Chmielik E; Krajewska J; Jarzab M; Oczko-Wojciechowska M; Czarniecka A; Jarzab B
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28829399
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The role of hepatic trans-arterial chemoembolization in metastatic medullary thyroid carcinoma: a specialist center experience and review of the literature.
    Grozinsky-Glasberg S; Bloom AI; Lev-Cohain N; Klimov A; Besiso H; Gross DJ
    Eur J Endocrinol; 2017 Apr; 176(4):463-470. PubMed ID: 28100632
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ATF4 Targets RET for Degradation and Is a Candidate Tumor Suppressor Gene in Medullary thyroid cancer.
    Bagheri-Yarmand R; Williams MD; Grubbs EG; Gagel RF
    J Clin Endocrinol Metab; 2017 Mar; 102(3):933-941. PubMed ID: 27935748
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Surgical Treatment of Medullary thyroid cancer.
    Machens A; Dralle H
    Recent Results Cancer Res; 2015; 204():187-205. PubMed ID: 26494390
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits.
    Pelizzo MR; Torresan F; Da Roit A; Merante Boschin I; Chondrogiannis S; Rampin L; Colletti PM; Vinjamury S; Perkins AJ; Rubello D
    Rev Esp Med Nucl Imagen Mol; 2015; 34(6):378-82. PubMed ID: 26420439
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Integration of a postoperative calcitonin measurement into an anatomical staging system improves initial risk stratification in medullary thyroid cancer.
    Yang JH; Lindsey SC; Camacho CP; Valente FO; Germano-Neto F; Machado AL; Mamone MC; Brodskyn F; Biscolla RP; Tuttle RM; Dias-da-Silva MR; Maciel RM
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):938-42. PubMed ID: 25376110
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Fewer cancer reoperations for medullary thyroid cancer after initial surgery according to ATA guidelines.
    Verbeek HH; Meijer JA; Zandee WT; Kramp KH; Sluiter WJ; Smit JW; Kievit J; Links TP; Plukker JT
    Ann Surg Oncol; 2015 Apr; 22(4):1207-13. PubMed ID: 25316487
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours.
    Sponziello M; Durante C; Boichard A; Dima M; Puppin C; Verrienti A; Tamburrano G; Di Rocco G; Redler A; Lacroix L; Bidart JM; Schlumberger M; Damante G; Russo D; Filetti S
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):8-13. PubMed ID: 24813658
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology.
    Agaram NP; Zhang L; Sung YS; Singer S; Antonescu CR
    Hum Pathol; 2014 May; 45(5):1084-91. PubMed ID: 24746215
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
    Salaun PY; Campion L; Bournaud C; Faivre-Chauvet A; Vuillez JP; Taieb D; Ansquer C; Rousseau C; Borson-Chazot F; Bardet S; Oudoux A; Cariou B; Mirallié E; Chang CH; Sharkey RM; Goldenberg DM; Chatal JF; Barbet J; Kraeber-Bodéré F
    J Nucl Med; 2012 Aug; 53(8):1185-92. PubMed ID: 22743249
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas.
    Moura MM; Cavaco BM; Pinto AE; Domingues R; Santos JR; Cid MO; Bugalho MJ; Leite V
    Br J Cancer; 2009 Jun; 100(11):1777-83. PubMed ID: 19401695
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?
    Bümming P; Ahlman H; Nilsson B; Nilsson O; Wängberg B; Jansson S
    Langenbecks Arch Surg; 2008 Sep; 393(5):699-703. PubMed ID: 18626656
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Investigation of V600E BRAF mutation in papillary thyroid carcinoma in the Polish population.
    Brzeziańska E; Pastuszak-Lewandoska D; Wojciechowska K; Migdalska-Sek M; Cyniak-Magierska A; Nawrot E; Lewiński A
    Neuro Endocrinol Lett; 2007 Aug; 28(4):351-9. PubMed ID: 17693984
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005.
    Grozinsky-Glasberg S; Benbassat CA; Tsvetov G; Feinmesser R; Peretz H; Shimon I; Lapidot M
    Thyroid; 2007 Jun; 17(6):549-56. PubMed ID: 17614776
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.